[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2005098046A3 - Methods for the determination of cell specific biomarkers - Google Patents

Methods for the determination of cell specific biomarkers Download PDF

Info

Publication number
WO2005098046A3
WO2005098046A3 PCT/US2005/010940 US2005010940W WO2005098046A3 WO 2005098046 A3 WO2005098046 A3 WO 2005098046A3 US 2005010940 W US2005010940 W US 2005010940W WO 2005098046 A3 WO2005098046 A3 WO 2005098046A3
Authority
WO
WIPO (PCT)
Prior art keywords
analysis
cells
nucleic acid
methods
sample
Prior art date
Application number
PCT/US2005/010940
Other languages
French (fr)
Other versions
WO2005098046A2 (en
Inventor
Shawn Mark O'hara
Denis Smimov
Original Assignee
Immunivest Corp
Shawn Mark O'hara
Denis Smimov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunivest Corp, Shawn Mark O'hara, Denis Smimov filed Critical Immunivest Corp
Publication of WO2005098046A2 publication Critical patent/WO2005098046A2/en
Publication of WO2005098046A3 publication Critical patent/WO2005098046A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides methods for the reduction of the considerate amount of white cell background that interferes with meaningful analysis of a patient's food sample when the analysis involves rare cell analysis. Nucleic acid profile analysis of targeted rare cells is obtained from an individual patient's enriched blood sample by subtracting the white cell nucleic acid content from the same enriched sample, prior to positive selection of the target cell content. Subsequent profile analysis of the remaining nucleic acids allow for specific mRNA expression profiles having improved signal-to-noise. The methods are useful in profiling of cells isolated from tissues or body fluids and serves as an adjunct to clinical diagnosis of diverse carcinomas including early stage detection and classification of circulating tumor cells. Monitoring of nucleic acid and protein profiles of cells either in conventional or microarray formats, facilitates management of therapeutic intervention including staging, monitoring response to therapy, confirmation of remission and detection of regression.
PCT/US2005/010940 2004-04-01 2005-03-31 Methods for the determination of cell specific biomarkers WO2005098046A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55852004P 2004-04-01 2004-04-01
US60/558,520 2004-04-01

Publications (2)

Publication Number Publication Date
WO2005098046A2 WO2005098046A2 (en) 2005-10-20
WO2005098046A3 true WO2005098046A3 (en) 2005-12-15

Family

ID=35125686

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/010940 WO2005098046A2 (en) 2004-04-01 2005-03-31 Methods for the determination of cell specific biomarkers

Country Status (1)

Country Link
WO (1) WO2005098046A2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US8168389B2 (en) 2006-06-14 2012-05-01 The General Hospital Corporation Fetal cell analysis using sample splitting
US8195415B2 (en) 2008-09-20 2012-06-05 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US8895298B2 (en) 2002-09-27 2014-11-25 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US9174222B2 (en) 2005-04-05 2015-11-03 The General Hospital Corporation Devices and method for enrichment and alteration of cells and other particles

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007147074A2 (en) 2006-06-14 2007-12-21 Living Microsystems, Inc. Use of highly parallel snp genotyping for fetal diagnosis
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
CN105190656B (en) 2013-01-17 2018-01-16 佩索纳里斯公司 Method and system for genetic analysis
GB2534067B (en) 2013-08-30 2021-07-21 Personalis Inc Methods and systems for genomic analysis
WO2015051275A1 (en) 2013-10-03 2015-04-09 Personalis, Inc. Methods for analyzing genotypes
WO2016070131A1 (en) 2014-10-30 2016-05-06 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365362B1 (en) * 1998-02-12 2002-04-02 Immunivest Corporation Methods and reagents for the rapid and efficient isolation of circulating cancer cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365362B1 (en) * 1998-02-12 2002-04-02 Immunivest Corporation Methods and reagents for the rapid and efficient isolation of circulating cancer cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HUANG Y.ET AL: "Dielectrophoretic cell separation and gene expression profiling on microelectronic chip arrays", ANALYTICAL CHEMISTRY, vol. 74, no. 14, 15 July 2002 (2002-07-15), pages 3362 - 3371, XP002255880 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895298B2 (en) 2002-09-27 2014-11-25 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US8986966B2 (en) 2002-09-27 2015-03-24 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US9174222B2 (en) 2005-04-05 2015-11-03 The General Hospital Corporation Devices and method for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US9017942B2 (en) 2006-06-14 2015-04-28 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US8168389B2 (en) 2006-06-14 2012-05-01 The General Hospital Corporation Fetal cell analysis using sample splitting
US9273355B2 (en) 2006-06-14 2016-03-01 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US9347100B2 (en) 2006-06-14 2016-05-24 Gpb Scientific, Llc Rare cell analysis using sample splitting and DNA tags
US8682594B2 (en) 2008-09-20 2014-03-25 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US8296076B2 (en) 2008-09-20 2012-10-23 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuoploidy by sequencing
US8195415B2 (en) 2008-09-20 2012-06-05 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US9353414B2 (en) 2008-09-20 2016-05-31 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US9404157B2 (en) 2008-09-20 2016-08-02 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing

Also Published As

Publication number Publication date
WO2005098046A2 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
WO2005098046A3 (en) Methods for the determination of cell specific biomarkers
WO2003035894A3 (en) Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
US7004901B2 (en) Method and kit for the transdermal determination of analyte concentration in blood
Iizuka et al. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma
WO2004020968A3 (en) Mutations in nod2 are associated with fibrostenosing disease in patients with crohn’s disease
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
Hartman et al. Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity
Miao et al. Clinical value of plasma cfDNA concentration and integrity in breast cancer patients
Kim et al. Biomarkers for chronic kidney disease in dogs: a comparison study
Nilsson et al. Differences in insulin sensitivity and risk markers due to gender and age in hypertensives
CN112424609A (en) Blood biomarkers of stroke
RU2568602C1 (en) Method for prediction of pathological process direction in patients with cerebral tumours
CN109791141B (en) Monitoring cancer recurrence and progression
WO2003069349A3 (en) Method for diagnosis of inflammatory diseases using mrp8/mrp14
BRPI0609044A2 (en) assay method and kit for the determination of thymidine kinase activity in a biological sample, use of assay method and / or kit, method for use in diagnosis, monitoring and / or prognosis of cell proliferation disorders or disorders, and method for use in compound screening
EP2505667A2 (en) Device and method for analysis of kidney failure
RU2320997C2 (en) Method for diagnosing chronic pancreatitis of alcoholic etiology
WO2006044566A3 (en) Autocrine growth factor receptors and methods
WO2002072752A3 (en) Forms of prostate specific antigens and methods for their detection
MX2022013833A (en) Methods for identifying a medical condition in a human subject.
Tiwari et al. Estimation of serum and salivary albumin and uric acid levels in oral submucous fibrosis and oral squamous cell carcinoma: a biochemical study
RU2255745C2 (en) Method for assay of treatment efficacy of patients with intracerebral malignant tumors
Quinn et al. Defining the Correlation Between Kidney Function and Histopathologi-cal Changes: SU-OR18
Gjerde et al. Low Birth Weight for Gestational Age and Risk of Different Groups of Kidney Disease During the First 50 Years of Life: SU-OR19
Norvik et al. Molecular Mechanisms Underlying Sex-Specific Association of Circulating Transforming Growth Factor в1 with the Risk of Accelerated Kidney Function Decline: SU-OR17

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)